Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting.
Glucocorticoids are essential for the increase in protein breakdown in skeletal muscle normally seen during fasting. To determine which proteolytic pathway(s) are activated upon fasting, leg muscles from fed and fasted normal rats were incubated under conditions that block or activate different proteolytic systems. After food deprivation (1 day), the nonlysosomal ATP-dependent process increased by 250%, as shown in experiments involving depletion of muscle ATP. Also, the maximal capacity of the lysosomal process increased 60-100%, but no changes occurred in the Ca(2+)-dependent or the residual energy-independent proteolytic processes. In muscles from fasted normal and adrenalectomized (ADX) rats, the protein breakdown sensitive to inhibitors of the lysosomal or Ca(2+)-dependent pathways did not differ. However, the ATP-dependent process was 30% slower in muscles from fasted ADX rats. Administering dexamethasone to these animals or incubating their muscles with dexamethasone reversed this defect. During fasting, when the ATP-dependent process rises, muscles show a two- to threefold increase in levels of ubiquitin (Ub) mRNA. However, muscles of ADX animals failed to show this response. Injecting dexamethasone into the fasted ADX animals increased muscle Ub mRNA within 6 h. Thus glucocorticoids activate the ATP-Ub-dependent proteolytic pathway in fasting apparently by enhancing the expression of components of this system such as Ub.
Wing
S S
SS
Department of Cellular and Molecular Physiology, Harvard Medical School, Boston, Massachusetts 02115.
Goldberg
A L
AL
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000315:Adrenalectomy; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology*; D005215:Fasting; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000235:genetics / Q000378:metabolism; D008247:Lysosomes / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D009119:Muscle Contraction; D009124:Muscle Proteins / Q000378:metabolism*; D009132:Muscles / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D014452:Ubiquitins / Q000235:genetics / Q000378:metabolism*
D008744:Methylamines; D009124:Muscle Proteins; D012333:RNA, Messenger; D014452:Ubiquitins; D000001:Calcimycin; D012313:RNA; D003907:Dexamethasone; D000255:Adenosine Triphosphate; C027451:methylamine; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D002118:Calcium